Mednet Logo
HomeCardiology
Cardiology

Cardiology

Expert discussions on heart failure, arrhythmias, interventional procedures, and cardiovascular risk management.

Recent Discussions

How do you re-stratify patients with a primary prevention ICD in need of a generator change if their LVEF has improved to >40% and they have not previously required any device therapies?

6
1 Answers

Mednet Member
Mednet Member
Cardiology · Hospital of the University of Pennsylvania

This is an important question on which there remains a lack of consensus. We had tried to address this through an observational study which was published a few years back:(Appropriateness of primary prevention implantable cardioverter-defibrillators at the time of generator replacement: are indicati...

For patients on immune checkpoint inhibitors presenting with chest pain, dyspnea, fatigue, and troponin elevation, would you recommend early initiation of high dose steroids for empiric treatment of ICI myocarditis while pursuing workup with coronary angiogram, echocardiogram, and/or cardiac MRI, or wait until alternative etiologies have been ruled out?

2
2 Answers

Mednet Member
Mednet Member
Cardiology · UConn Health

This question raises an important point that the clinical presentation of ICI-associated myocarditis often overlaps with other cardiovascular disorders, including acute coronary syndrome, chronic CAD, congestive heart failure, and other nonischemic cardiomyopathies. Therefore, prompt initiation of w...

How do you manage patients blood pressures while on anti-angiogenic TKIs?

1 Answers

Mednet Member
Mednet Member
Medical Oncology · Myo Thant, MD

Advise patients to take BP daily, and inform us if the BP is high.

Should all patients with a remote history of immunotherapy, chemotherapy and/or radiation therapy have a baseline TTE regardless of ASCVD risk?

2 Answers

Mednet Member
Mednet Member
Cardiology · UConn Health

The current ASCVD risk assessment calculators we have available do not contain cancer-specific parameters and thus are inadequate for accurate assessment of a cancer survivor's risk of developing CHF and ischemic heart disease. If patients have received mediastinal radiation therapy or high-dose ant...

What is your approach to considering geriatric patients for complex PCI given their overall frailty and increased risk of complications such as bleeding and stroke?

2 Answers

Mednet Member
Mednet Member
Cardiology · University of Arizona College of Medicine

I would do everything I could with respect to medical and lifestyle therapy for such a patient. They are at very high risk for a bad outcome in the cath lab.

When would you consider initiating GDMT for new onset HF in the geriatric population?

1 Answers

Mednet Member
Mednet Member
Cardiology · University of Arizona College of Medicine

I would always treat with GDMT but would start low and slowly advance watching for AE's.

What is a reasonable blood pressure goal for refractory HTN in the geriatric population?

1 Answers

Mednet Member
Mednet Member
Cardiology · Washington University School of Medicine

Resistant hypertension is defined as a blood pressure that remains above goal despite concurrent use of three antihypertensive agents of different classes taken at maximally tolerated doses, one of which should be a diuretic. Refractory hypertension is defined as uncontrolled blood pressure despite ...

How do you decide on an outpatient maintenance diuretic regimen for patients approaching discharge for ADHF?

2 Answers

Mednet Member
Mednet Member
Cardiology · Heart And Sleep Clinics Of America

Good question. More from my personal observational experience. I reduce the dose to minimal once the patient is well compensated clinically and other pillars are tolerated well. If the SGLT2i, ARNI, and beta blockers are already on board and the patient coming off the IV lasix, I will add low-dose M...

Should we be more concerned about cardiac toxicity following breast radiotherapy?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

The way I interpret the data with all caveats that threshold dose and time period for any cardiac morbidity is significantly lower than what was expected. For that reason, all efforts should be made to avoid any direct photon beam wherever possible to go through any portion of heart by using any one...

How do you counsel men with prostate cancer on the cardiovascular risks of androgen deprivation therapy?

1
1 Answers

Mednet Member
Mednet Member
Medical Oncology · Duke University School of Medicine

This is a complex issue and depends on the specific setting (concurrent with XRT), the risk of the patient, and the specific CV risks of that patient. In the metastatic setting, there is almost never a contraindication to hormonal therapy given that prostate cancer is the likely cause of death in th...